Cargando…
Measuring brain glucose metabolism in order to predict response to antidepressant or placebo: A randomized clinical trial
There is critical need for a clinically useful tool to predict antidepressant treatment outcome in major depressive disorder (MDD) to reduce suffering and mortality. This analysis sought to build upon previously reported antidepressant treatment efficacy prediction from 2-[(18)F]-fluorodeoxyglucose...
Autores principales: | Hill, Kathryn R., Gardus, John D., Bartlett, Elizabeth A., Perlman, Greg, Parsey, Ramin V., DeLorenzo, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551925/ https://www.ncbi.nlm.nih.gov/pubmed/34689056 http://dx.doi.org/10.1016/j.nicl.2021.102858 |
Ejemplares similares
-
Evaluation of brain structure and metabolism in currently depressed adults with a history of childhood trauma
por: Jones, Joshua S., et al.
Publicado: (2022) -
Circadian rhythm biomarker from wearable device data is related to concurrent antidepressant treatment response
por: Ali, Farzana Z., et al.
Publicado: (2023) -
Investigating The Relationship Between Hippocampus:Dentate Gyrus Volume and Hypothalamus Metabolism in Participants with Major Depressive Disorder
por: Lin, Karen, et al.
Publicado: (2023) -
Neuroinflammation in World Trade Center responders at midlife: A pilot study using [(18)F]-FEPPA PET imaging
por: Deri, Yael, et al.
Publicado: (2021) -
In Vivo Brain Imaging, Biodistribution, and Radiation Dosimetry Estimation of [(11)C]Celecoxib, a COX-2 PET Ligand, in Nonhuman Primates
por: Kumar, J. S. Dileep, et al.
Publicado: (2018)